Skip to main content

Advertisement

SpringerLink
Log in

New Chemiluminescent Substrates of Paraoxonase 1 with Improved Specificity: Synthesis and Properties

  • Published:
Applied Biochemistry and Biotechnology Aims and scope Submit manuscript

Abstract

Paraoxonase 1 (PON1) is an important hydrolase, and the enzyme activity decreases in patients with liver disease, diabetes, coronary heart disease, etc. Phenyl acetate and organophosphates are usually employed as substrates for serum PON1 activity assay. However, phenyl acetate for arylesterase activity assay exhibits disadvantage of high background. According to properties of PON1, four new chemiluminescent acridinium esters were designed, prepared through three steps, and characterized with 1H NMR and mass spectrometry (MS) data, and their properties as PON1 substrates were investigated. The hydrolyses of the four compounds catalyzed by recombinant human PON1 (rhPON1) (or serum) followed first-order kinetics within 22 min. The PON1 activator (NaCl, 0.10 mol L−1) could boost the rhPON1-mediated and serum-mediated hydrolyses of the acridinium esters to 2.01 ~ 2.26 folds, but 1.0 mol L−1 NaCl decreased the serum arylesterase activity. RhPON1 showed selectivity over other serum esterases such as lipase, acetylcholinesterase, and esterase D more than 300 folds. By using ethylene diamine tetraacetic acid (EDTA) inhibitor, the specificities of the four substrates toward serum PON1 were determined as 78.3 ~ 92.9 %, which is improved than that of the model compound 9-(4-chloro-phenoxycarbonyl)-10-methylacridinium ester triflate. Due to low toxicity, high specificity, and sensitivity of the substrates, they are useful for serum PON1 activity assay.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Scheme 1
Scheme 2
Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

Abbreviations

PON1:

Paraoxonase 1

rhPON1:

Recombinant human PON1

CL:

Chemiluminescent/chemiluminescence

CPOCMA:

9-(4-chlorophenoxycarbonyl)-10-methylacridinium triflate ester

EDTA:

Ethylene diamine tetraacetic acid

References

  1. Durrington, P. N., Mackness, B., & Mackness, M. I. (2001). Paraoxonase and atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology, 21, 473–480.

    Article  CAS  Google Scholar 

  2. Gan, K., Smolen, A., Eckerson, H. W., & La Du, B. N. (1991). Purification of human serum paraoxonase arylesterase-evidence for one esterase catalyzing both activities. Drug Metabolism and Disposition, 19, 100–106.

    CAS  Google Scholar 

  3. Mackness, M. I., Arrol, S., & Durrington, P. N. (1991). Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein. FEBS Letters, 286, 152–154.

    Article  CAS  Google Scholar 

  4. Aydin, S., Sahin, I., Aydin, S., Aksoy, A., & Citil, C. (2012). The past and present of paraoxonase enzyme: its role in the cardiovascular system and some diseases. Journal of Medical Biochemistry, 31, 161–173.

    Article  CAS  Google Scholar 

  5. Mehdi, M. M., & Rizvi, S. I. (2012). Human plasma paraoxonase 1 (PON1) arylesterase activity during aging: correlation with susceptibility of LDL oxidation. Archives of Medical Research, 43, 438–443.

    Article  CAS  Google Scholar 

  6. Caraballo, J. C., Borcherding, J., Rector, M., Hornick, E., Stoltz, D., Zabner, J., & Comellas, A. P. (2014). Role of PON in anoxia-reoxygenation injury: a drosophila melanogaster transgenic model. PLoS One, 9, e84434.

    Article  Google Scholar 

  7. Bonello, L., Bonello, N., Grosdidier, C., & Camoin-Jau, L. (2011). Unveiling the mysteries of clopidogrel metabolism and efficacy. Clinical Pharmacology and Therapeutics, 90, 774–776.

    Article  CAS  Google Scholar 

  8. Hioki, T., Fukami, T., Nakajima, M., & Yokoi, T. (2011). Human paraoxonase 1 is the enzyme responsible for pilocarpine hydrolysis. Drug Metabolism and Disposition, 39, 1345–1352.

    Article  CAS  Google Scholar 

  9. Saade, M., Magdalou, J., Ouaini, N., & Greige-Gerges, H. (2009). Stability of cucurbitacin E in human plasma: chemical hydrolysis and role of plasma esterases. Biopharmaceutics and Drug Disposition, 30, 389–397.

    Article  CAS  Google Scholar 

  10. Macharia, M., Hassan, M. S., Blackhurst, D., Erasmus, R. T., & Matsha, T. E. (2012). The growing importance of PON1 in cardiovascular health: a review. Journal of Cardiovascular Medicine, 13, 443–453.

    Article  CAS  Google Scholar 

  11. Goswami, B., Tayal, D., Gupta, N., & Mallikaet, V. (2009). Paraoxonase: a multifaceted biomolecule. Clinica Chimica Acta, 410, 1–12.

    Article  CAS  Google Scholar 

  12. Richter, R. J., Jarvik, G. P., & Furlong, C. E. (2009). Paraoxonase 1 (PON1) status and substrate hydrolysis. Toxicology and Applied Pharmacology, 235, 1–9.

    Article  CAS  Google Scholar 

  13. Pera-Kajan, J., & Jakubowski, H. (2012). Paraoxonase 1 and homocysteine metabolism. Amino Acids, 43, 1405–1417.

    Article  Google Scholar 

  14. Costa, L. G., Giordano, G., & Furlong, C. E. (2011). Pharmacological and dietary modulators of paraoxonase 1 (PON1) activity and expression: the hunt goes on. Biochemical Pharmacology, 81, 337–344.

    Article  CAS  Google Scholar 

  15. Ceron, J. J., Tecles, F., & Tvarijonaviciute, A. (2014). Serum paraoxonase 1 (PON1) measurement: an update. BMC Veterinary Research, 10, e74.

    Article  Google Scholar 

  16. Camps, J., Marsillach, J., & Joven, J. (2009). The paraoxonases: role in human diseases and methodological difficulties in measurement. Critical Reviews in Clinical Laboratory Sciences, 46, 83–106.

    Article  CAS  Google Scholar 

  17. Costa, L. G., Cole, T. B., Vitalone, A., & Furlong, C. E. (2005). Measurement of paraoxonase (PON1) status as a potential biomarker of susceptibility to organophosphate toxicity. Clinica Chimica Acta, 352, 37–47.

    Article  CAS  Google Scholar 

  18. Soukharev, S., & Hammond, D. J. (2004). A fluorogenic substrate for detection of organophosphatase activity. Analytical Biochemistry, 327, 140–148.

    Article  CAS  Google Scholar 

  19. Mu, X., Yu, N., Wang, C., Zou, X., Abulimite, Z., & Xia, Z. (2012). Evaluation of a new substrate for measurement of serum PON arylesterase activity. Talanta, 88, 711–716.

    Article  CAS  Google Scholar 

  20. Mu, X. (2006). Synthesis of chemiluminescent compounds. PhD thesis. Swansea: Swansea University.

  21. Ben-David, M., Elias, M., Filippi, J., Duñach, E., Silman, I., Sussman, J. L., & Tawfik, D. S. (2012). Catalytic versatility and backups in enzyme active sites: the case of serum paraoxonase 1. Journal of Molecular Biology, 418, 181–196.

    Article  CAS  Google Scholar 

  22. Eckerson, H. W., Wyte, C. M., & La Du, B. N. (1983). The human serum paraoxonase/arylesterase polymorphism. American Journal of Human Genetics, 35, 1126–1138.

    CAS  Google Scholar 

  23. Haagen, L., & Brock, A. (1992). A new automated-method for phenotyping arylesterase (EC 3112) based upon inhibition of enzymatic-hydrolysis of 4-nitrophenyl acetate by phenyl acetate. European Journal of Clinical Chemistry and Clinical Biochemistry, 30, 391–395.

    CAS  Google Scholar 

  24. Krzyminski, K., Ozog, A., Malecha, P., Roshal, A. D., Wroblewska, A., Zadykowicz, B., & Blazejowski, J. (2011). Chemiluminogenic features of 10-methyl-9-(phenoxycarbonyl)acridinium trifluoromethanesulfonates alkyl substituted at the benzene ring in aqueous media. Journal of Organic Chemistry, 76, 1072–1085.

    Article  CAS  Google Scholar 

  25. Primo-Parmo, S. L., Sorenson, R. C., Teiber, J., & La Du, B. N. (1996). The human serum paraoxonase arylesterase gene (PON1) is one member of a multigene family. Genomics, 33, 498–507.

    Article  CAS  Google Scholar 

  26. Draganov, D. I., Teiber, J. F., Speelman, A., Osawa, Y., Sunahara, R., & La Du, B. N. (2005). Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities. Journal of Lipid Research, 46, 1239–1247.

    Article  CAS  Google Scholar 

  27. Ng, C. J., Wadleigh, D. J., Gangopadhyay, A., Hama, S., Grijalva, V. R., Navab, M., Fogelman, A. M., & Reddy, S. T. (2001). Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein. Journal of Biological Chemistry, 276, 44444–44449.

    Article  CAS  Google Scholar 

  28. Aviram, M., & Rosenblat, M. (2004). Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development. Free Radical Biology and Medicine, 37, 1304–1316.

    Article  CAS  Google Scholar 

  29. Draganov, D. I., Stetson, P. L., Watson, C. E., Billecke, S. S., & La Du, B. N. (2000). Rabbit serum paraoxonase 3 (PON3) is a high density lipoprotein-associated lactonase and protects low density lipoprotein against oxidation. Journal of Biological Chemistry, 275, 33435–33442.

    Article  CAS  Google Scholar 

  30. La Du, B. N. (2001). Is paraoxonase-3 another HDL-associated protein protective against atherosclerosis? Arteriosclerosis, Thrombosis, and Vascular Biology, 21, 467–468.

    Article  Google Scholar 

  31. Fukami, T., & Yokoi, T. (2012). The emerging role of human esterases. Drug Metabolism and Pharmacokinetics, 27, 466–477.

    Article  CAS  Google Scholar 

  32. Bahar, F. G., Ohura, K., Ogihara, T., & Imai, T. (2012). Species difference of esterase expression and hydrolase activity in plasma. Journal of Pharmaceutical Sciences, 101, 3979–3988.

    Article  CAS  Google Scholar 

  33. Parra, S., Alonso-Villaverde, C., Coll, B., Ferre, N., Marsillach, J., Aragones, G., Mackness, M., Mackness, B., Masana, L., Joven, J., & Camps, J. (2007). Serum paraoxonase-1 activity and concentration are influenced by human immunodeficiency virus infection. Atherosclerosis, 194, 175–181.

    Article  CAS  Google Scholar 

  34. Grenner, G., Deutsch, G., Schmidtberger, R., & Dati, F. (1982). A highly sensitive enzyme-immunoassay for the determination of pancreatic lipase. Journal of Clinical Chemistry and Clinical Biochemistry, 20, 515–519.

    CAS  Google Scholar 

  35. Lee, W., Wheatley, W., Benedict, W. F., Huang, C., & Lee, E. (1986). Purification, biochemical-characterization, and biological function of human esterase-D. Proceedings of the National Academy of Sciences of the United States of America, 83, 6790–6794.

    Article  CAS  Google Scholar 

  36. López-Flores, I., Lacasãna, M., Blanco-Muñoz, J., Aguilar-Gardữno, C., Sanchez-Villegasb, P., Pérez-Méndez, O. A., & Gamboa-avilad, R. (2009). Relationship between human paraoxonase-1 activity and PON1 polymorphisms in Mexican workers exposed to organophosphate pesticides. Toxicological Letters, 188, 84–90.

    Article  Google Scholar 

  37. Ahmad, S., Carter, J. J., & Scott, J. E. (2010). A homogeneous cell-based assay for measurement of endogenous paraoxonase 1 activity. Analytical Biochemistry, 400, 1–9.

    Article  CAS  Google Scholar 

  38. Pla, A., Rodrigo, L., Hernández, L., Gil, F., & Lopez, O. (2007). Effect of metal ions and calcium on purified PON1 and PON3 from rat liver. Chemico-Biological Interactions, 167, 63–70.

    Article  CAS  Google Scholar 

  39. La Du, B. N. (1988). The human serum paraoxonase/arylesterase polymorphism. American Journal of Human Genetics, 43, 227–229.

    Google Scholar 

Download references

Acknowledgments

This work was financially funded by Natural Science Foundation of Chongqing China (Nos. cstc2014jcsfglyjs0013, cstc2011BB5090) and NSFC (No.20805060). Also, thanks are given to the hospital of Chongqing University for kindly collecting human blood serum samples.

Author information

Authors and Affiliations

  1. College of Chemistry & Chemical Engineering, Chongqing University, Chongqing, 400044, China

    Zulipiyan Abulimite, Xiaojing Mu, Shangyou Xiao, Quandan Li & Gang Chen

  2. College of Chemistry, Huazhong University of Science and Technology, Wuhan, 430074, China

    Min Liu

Authors
  1. Zulipiyan Abulimite
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xiaojing Mu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shangyou Xiao
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Min Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Quandan Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Gang Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Xiaojing Mu.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Abulimite, Z., Mu, X., Xiao, S. et al. New Chemiluminescent Substrates of Paraoxonase 1 with Improved Specificity: Synthesis and Properties. Appl Biochem Biotechnol 176, 301–316 (2015). https://doi.org/10.1007/s12010-015-1575-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12010-015-1575-5

Keywords

Search

Navigation